CorMedix (CRMD) Short Interest Ratio & Short Volume $10.73 -0.27 (-2.45%) Closing price 04:00 PM EasternExtended Trading$10.68 -0.05 (-0.51%) As of 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CorMedix Short Interest DataCorMedix (CRMD) has a short interest of 16.67 million shares. This marks a 40.20% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.9, indicating that it would take 4.9 days of the average trading volume of 2.25 million shares to cover all short positions.Current Short Interest16,670,000 sharesPrevious Short Interest11,890,000 sharesChange Vs. Previous Month+40.20%Dollar Volume Sold Short$210.88 millionShort Interest Ratio4.9 Days to CoverLast Record DateSeptember 15, 2025Outstanding Shares78,060,000 sharesPercentage of Shares Shorted21.36%Today's Trading Volume1,934,980 sharesAverage Trading Volume2,245,211 sharesToday's Volume Vs. Average86% Short Selling CorMedix? Sign up to receive the latest short interest report for CorMedix and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCRMD Short Interest Over TimeCRMD Days to Cover Over TimeCRMD Percentage of Float Shorted Over Time CorMedix Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/202516,670,000 shares $210.88 million +40.2%N/A4.9 $12.65 8/31/202511,890,000 shares $176.33 million -16.2%16.8%3.7 $14.83 8/15/202514,180,000 shares $183.35 million +32.8%N/A5.8 $12.93 7/31/202510,680,000 shares $124.64 million +6.3%15.1%4.6 $11.67 7/15/202510,050,000 shares $114.27 million +4.2%N/A4.9 $11.37 6/30/20259,650,000 shares $118.89 million +12.3%15.0%4.8 $12.32 6/15/20258,590,000 shares $125.07 million +0.7%13.4%4 $14.56 5/31/20258,530,000 shares $102.96 million +1.0%14.8%4.4 $12.07 5/15/20258,450,000 shares $98.78 million +5.1%14.7%4.6 $11.69 4/30/20258,040,000 shares $73.89 million -2.7%N/A4.6 $9.19 Get the Latest News and Ratings for CRMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CorMedix and its competitors with MarketBeat's FREE daily newsletter. 4/15/20258,260,000 shares $61.12 million +4.3%14.4%5.8 $7.40 3/31/20257,920,000 shares $48.79 million -3.2%13.8%5.3 $6.16 3/15/20258,180,000 shares $85.64 million +3.8%14.2%6.3 $10.47 2/28/20257,880,000 shares $81.64 million +6.6%13.7%7.7 $10.36 2/15/20257,390,000 shares $77.45 million +2.9%12.8%7.2 $10.48 1/31/20257,180,000 shares $73.74 million +1.4%N/A6.6 $10.27 1/15/20257,080,000 shares $84.25 million +1.1%N/A5.5 $11.90 12/31/20247,000,000 shares $56.70 million +4.0%N/A5.6 $8.10 12/15/20246,730,000 shares $56.40 million -2.3%N/A5.8 $8.38 11/30/20246,890,000 shares $67.94 million +0.7%N/A5.8 $9.86 11/15/20246,840,000 shares $70.66 million +8.9%N/A5.8 $10.33 10/31/20246,280,000 shares $63.15 million -20.1%N/A5.4 $10.06 10/15/20247,860,000 shares $79.31 million -15.2%N/A8.7 $10.09 9/30/20249,270,000 shares $74.90 million -10.7%N/A11.4 $8.08 9/15/202410,380,000 shares $72.14 million +2.7%N/A14.7 $6.95 8/31/202410,110,000 shares $63.09 million -2.0%N/A15.6 $6.24 8/15/202410,320,000 shares $49.48 million +1.2%N/A18.9 $4.80 7/31/202410,200,000 shares $46.72 million -1.5%N/A20.2 $4.58 7/15/202410,360,000 shares $50.76 million +5.6%N/A19.5 $4.90 6/30/20249,810,000 shares $42.48 million -1.6%N/A15.3 $4.33 6/15/20249,970,000 shares $47.06 million +1.4%N/A15.6 $4.72 5/31/20249,830,000 shares $51.80 million +1.6%N/A14.6 $5.27 5/15/20249,680,000 shares $50.82 million -1.8%N/A14.9 $5.25 4/30/20249,860,000 shares $51.81 million +5.1%N/A16.1 $5.26 4/15/20249,380,000 shares $50.46 million +13.7%N/A16 $5.38 3/31/20248,250,000 shares $34.98 million +6.2%N/A18.6 $4.24 3/15/20247,770,000 shares $29.60 million +0.7%N/A17.7 $3.81 2/29/20247,720,000 shares $27.33 million -0.1%N/A17.9 $3.54 2/15/20247,730,000 shares $25.28 million +7.5%N/A16.4 $3.27 1/31/20247,190,000 shares $21.21 million +2.0%N/A8.6 $2.95 1/15/20247,050,000 shares $24.46 million -0.6%N/A8.4 $3.47 12/31/20237,090,000 shares $26.66 million -1.5%N/A8.3 $3.76 12/15/20237,200,000 shares $23.83 million -8.1%N/A8.5 $3.31 11/30/20237,830,000 shares $25.45 million +17.6%N/A9.3 $3.25 11/15/20236,660,000 shares $22.18 million +17.1%N/A8.1 $3.33 10/31/20235,690,000 shares $19.80 million +11.4%N/A12.1 $3.48 10/15/20235,110,000 shares $17.07 million +3.0%N/A10.8 $3.34 9/30/20234,960,000 shares $18.35 million +6.4%N/A9.8 $3.70 9/15/20234,660,000 shares $18.22 million +15.4%N/A6.2 $3.91 8/31/20234,040,000 shares $16.44 million +0.3%N/A5.2 $4.07 8/15/20234,030,000 shares $17.17 million -7.6%N/A5.5 $4.26 7/31/20234,360,000 shares $19.27 million -16.3%N/A5.8 $4.42 7/15/20235,210,000 shares $20.27 million -0.2%N/A7.5 $3.89 6/30/20235,220,000 shares $20.70 million +71.7%N/A7.9 $3.97 6/15/20233,040,000 shares $15.72 million +16.0%N/A6.2 $5.17 5/31/20232,620,000 shares $12.60 million +20.7%N/A8.4 $4.81 5/15/20232,170,000 shares $11.18 million -2.3%N/A7 $5.15 4/30/20232,220,000 shares $10.97 million +8.3%N/A8.6 $4.94 4/15/20232,050,000 shares $10.80 million +3.0%N/A8.4 $5.27 3/31/20231,990,000 shares $8.24 million +19.2%N/A8.2 $4.14 3/15/20231,670,000 shares $5.90 million +4.4%N/A7.5 $3.53 2/28/20231,600,000 shares $6.48 million -0.6%N/A7.1 $4.05 2/15/20231,610,000 shares $7.23 million -3.0%N/A7.3 $4.49 1/31/20231,660,000 shares $7.20 million +1.2%N/A6.7 $4.34 1/15/20231,640,000 shares $7.27 million +6.5%N/A7 $4.43 12/30/20221,540,000 shares $6.50 million No ChangeN/A7.2 $4.22 12/15/20221,540,000 shares $6.38 million -1.3%N/A8 $4.14 11/30/20221,560,000 shares $6.49 million -4.9%N/A7.9 $4.16 11/15/20221,640,000 shares $6.05 million No ChangeN/A8.5 $3.69 10/31/20221,640,000 shares $5.03 million +5.1%N/A5.2 $3.07 10/15/20221,560,000 shares $4.60 million -5.5%N/A4.1 $2.95 9/30/20221,650,000 shares $4.67 million +1.9%N/A4 $2.83 9/15/20221,620,000 shares $5.65 million -5.3%N/A3.1 $3.49 8/31/20221,710,000 shares $6.04 million -5.0%N/A3.1 $3.53 7/30/20212,450,000 shares $0.00 +0.4%6.7%6.9 $0.00 7/15/20212,440,000 shares $0.00 -2.4%6.6%6.9 $0.00 6/30/20212,500,000 shares $0.00 -1.2%6.8%6.1 $0.00 6/15/20212,530,000 shares $0.00 -1.9%6.9%5.9 $0.00 5/28/20212,580,000 shares $0.00 -0.8%7.0%5.1 $0.00 5/14/20212,600,000 shares $0.00 +0.4%N/A2.8 $0.00 4/30/20212,590,000 shares $0.00 +2.8%N/A2.6 $0.00 4/15/20212,520,000 shares $20.49 million -4.2%N/A2 $8.13 3/31/20212,630,000 shares $22.59 million -4.4%N/A2.1 $8.59 3/15/20212,750,000 shares $25.77 million +4.2%N/A2.2 $9.37 2/26/20212,640,000 shares $22.97 million -0.8%N/A2.3 $8.70 2/12/20212,660,000 shares $20.46 million -15.0%N/A3.2 $7.69 1/29/20213,130,000 shares $51.74 million +3.0%N/A4.7 $16.53 1/15/20213,040,000 shares $42.86 million -0.3%N/A7.8 $14.10 12/31/20203,050,000 shares $22.54 million -1.3%N/A8.8 $7.39 12/15/20203,090,000 shares $24.97 million -5.8%N/A9 $8.08 11/30/20203,280,000 shares $29.39 million +9.3%N/A8.1 $8.96 11/15/20203,000,000 shares $17.07 million -3.5%N/A7.1 $5.69 10/30/20203,110,000 shares $15.89 million No ChangeN/A7.1 $5.11 10/15/20203,110,000 shares $18.26 million -12.9%N/A5.9 $5.87 CRMD Short Interest - Frequently Asked Questions What is CorMedix's current short interest? Short interest is the volume of CorMedix shares that have been sold short but have not yet been closed out or covered. As of September 15th, traders have sold 16,670,000 shares of CRMD short. Learn More on CorMedix's current short interest. What is a good short interest ratio for CorMedix? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRMD shares currently have a short interest ratio of 5.0. Learn More on CorMedix's short interest ratio. Which institutional investors are shorting CorMedix? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of CorMedix: Group One Trading LLC, and Jane Street Group LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is CorMedix's short interest increasing or decreasing? CorMedix saw a increase in short interest in September. As of September 15th, there was short interest totaling 16,670,000 shares, an increase of 40.2% from the previous total of 11,890,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does CorMedix's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to CorMedix: Scholar Rock Holding Corporation (16.73%), Zai Lab Limited Unsponsored ADR (4.37%), Mirum Pharmaceuticals, Inc. (14.93%), ACADIA Pharmaceuticals Inc. (4.73%), Ascentage Pharma Group International - Unsponsored ADR (0.02%), ADMA Biologics Inc (6.60%), Lantheus Holdings, Inc. (11.21%), Telix Pharmaceuticals Limited (0.04%), Centessa Pharmaceuticals PLC Sponsored ADR (6.47%), uniQure N.V. (15.07%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks. What does it mean to sell short CorMedix stock? Short selling CRMD is an investing strategy that aims to generate trading profit from CorMedix as its price is falling. CRMD shares are trading down $0.27 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CorMedix? A short squeeze for CorMedix occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CRMD, which in turn drives the price of the stock up even further. How often is CorMedix's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRMD, twice per month. The most recent reporting period available is September, 15 2025. More Short Interest Resources from MarketBeat Related Companies SRRK Short Interest Data ZLAB Short Interest Data MIRM Short Interest Data ACAD Short Interest Data AAPG Short Interest Data ADMA Short Interest Data LNTH Short Interest Data TLX Short Interest Data CNTA Short Interest Data QURE Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CRMD) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenIf you're a futures trader (or want to be one), this could be the biggest shift you'll ever see in the prop fi...Neuro Street Trading Academy | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored"I'm risking my reputation on this"If I'm right about what's coming, this could be the most important book you'll read this yearCrypto 101 Media | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CorMedix Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share CorMedix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
